1-4 of 4
Vaishali Sanchorawala
Close
Sort by
Journal Articles

The clinical trials landscape in immunoglobulin light chain amyloidosis: a systematic review

Ramya Ramachandran, Darshi Shah, Catherine Luo, Veer Shah, Edward R. Scheffer Cliff, Vaishali Sanchorawala, Suzanne Lentzsch, Rajshekhar Chakraborty
Journal: Blood Advances
Blood Adv (2024) 8 (13): 3464–3467.
https://doi.org/10.1182/bloodadvances.2024012737
Published: 2024
Includes: Supplemental data
Journal Articles

Predictors of treatment response and survival outcomes in patients with advanced cardiac AL amyloidosis

Clinical Trials & Observations
Joshua N. Gustine, Andrew Staron, Lisa Mendelson, Tracy Joshi, Deepa M. Gopal, Omar K. Siddiqi, Frederick L. Ruberg, Vaishali Sanchorawala
Journal: Blood Advances
Blood Adv (2023) 7 (20): 6080–6091.
https://doi.org/10.1182/bloodadvances.2023010324
Published: 2023
Includes: Supplemental data
Journal Articles

Assessment of minimal residual disease using multiparametric flow cytometry in patients with AL amyloidosis

Clinical Trials & Observations
Andrew Staron, Eric J. Burks, John C. Lee, Shayna Sarosiek, J. Mark Sloan, Vaishali Sanchorawala
Journal: Blood Advances
Blood Adv (2020) 4 (5): 880–884.
https://doi.org/10.1182/bloodadvances.2019001331
Published: 2020
Journal Articles

Delay treatment of AL amyloidosis at relapse until symptomatic: devil is in the details

Vaishali Sanchorawala
Journal: Blood Advances
Blood Adv (2019) 3 (2): 216–218.
https://doi.org/10.1182/bloodadvances.2018021261
Published: 2019